Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2020 to Q4 2024

Type / Class
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
Symbol
BNR on Nasdaq
Shares outstanding
9,036,176
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Kynam Capital Management, LP 11% 994,883 Kynam Capital Management, LP 30 Sep 2025

Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q4 0 $0 -$64,484 0
2024 Q3 21,212 $64,484 -$761 $3.04 1
2024 Q2 22,097 $136,094 -$16,092,890 $3.62 2
2024 Q1 20,649,684 $15,057,860 +$402,638 $0.73 20
2023 Q4 20,064,461 $18,682,043 -$666,244 $0.93 19
2023 Q3 20,753,481 $20,117,008 -$734,856 $0.97 27
2023 Q2 21,379,023 $46,159,776 -$939,058 $2.15 31
2023 Q1 21,663,295 $60,814,324 -$819,632 $2.81 32
2022 Q4 22,069,051 $49,630,619 -$3,239,921 $2.25 40
2022 Q3 23,231,970 $55,465,986 -$4,349,805 $2.39 47
2022 Q2 24,767,928 $71,168,352 -$30,970,776 $2.91 48
2022 Q1 29,510,597 $274,402,530 +$18,724,219 $9.29 43
2021 Q4 25,495,461 $241,308,981 -$36,609,937 $9.53 57
2021 Q3 27,470,929 $491,180,341 +$4,753,957 $17.88 82
2021 Q2 26,920,427 $792,304,929 +$102,643,853 $29.46 79
2021 Q1 23,578,976 $634,746,122 +$86,851,459 $26.92 51
2020 Q4 20,526,046 $474,167,436 +$99,408,578 $23.10 57
2020 Q3 15,975,265 $400,530,030 +$3,105,150 $25.08 38
2020 Q2 15,781,393 $426,251,845 +$426,251,845 $27.01 47